Successful use of tPA for thrombolysis in COVID related ARDS: a case series

We describe successful usage of low dose Tissue plasminogen activator (tPA) (30–50 mg) in three COVID19 critically ill patients, who were in worsening respiratory failure in-spite of being on therapeutic anticoagulation. All patients had respiratory rate > 40; FiO(2) > 0.7(on NIV); PiO(2)/FiO(...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Abhishek, Saigal, Saurabh, Niwariya, Yogesh, Sharma, Jaiprakash, Singh, Pooja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330540/
https://www.ncbi.nlm.nih.gov/pubmed/32617806
http://dx.doi.org/10.1007/s11239-020-02208-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330540/
https://www.ncbi.nlm.nih.gov/pubmed/32617806
http://dx.doi.org/10.1007/s11239-020-02208-2

Ejemplares similares